Stryker (SYK) Change in Accured Expenses (2009 - 2026)
Stryker's (SYK) quarterly Change in Accured Expenses came in at $298.0 million in Q2 2026, down 23.2% year-over-year from $388.0 million in Q2 2025, and up 145.57% quarter-over-quarter from -$654.0 million in Q1 2026.
Analysis
Stryker (SYK) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Change in Accured Expenses for 18 consecutive years, with $298.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Accured Expenses fell 23.2% year-over-year to $298.0 million in Q2 2026; TTM through Jun 2026 was $78.0 million, a 87.23% decrease from a year earlier, with the FY2025 full-year figure at $318.0 million, up 329.73% from the prior year.
- Change in Accured Expenses was $298.0 million for Q2 2026 at Stryker, up from -$654.0 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $429.0 million in Q3 2024 and troughed at -$654.0 million in Q1 2026.
- A 5-year average of $39.3 million and a median of $195.5 million in 2022 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses sank 107.5% in 2024 and jumped 2255.56% in 2025, its largest moves.
- Over 5 years, Change in Accured Expenses stood at $151.0 million in 2022, then surged by 143.05% to $367.0 million in 2023, then slipped by 18.8% to $298.0 million in 2024, then surged by 32.89% to $396.0 million in 2025, then declined by 24.75% to $298.0 million in 2026.
- The last three Change in Accured Expenses figures came in at $298.0 million (Q2 2026), -$654.0 million (Q1 2026), and $396.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -74.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 92.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 298.00 Mn |
| Mar 31, 2026 | -654.00 Mn |
| Dec 31, 2025 | 396.00 Mn |
| Sep 30, 2025 | 38.00 Mn |
| Jun 30, 2025 | 388.00 Mn |
| Mar 31, 2025 | -504.00 Mn |
| Dec 31, 2024 | 298.00 Mn |
| Sep 30, 2024 | 429.00 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Mar 31, 2024 | -635.00 Mn |
| Dec 31, 2023 | 367.00 Mn |
| Sep 30, 2023 | 328.00 Mn |
| Jun 30, 2023 | 240.00 Mn |
| Mar 31, 2023 | -419.00 Mn |
| Dec 31, 2022 | 151.00 Mn |
| Sep 30, 2022 | 262.00 Mn |
| Jun 30, 2022 | 91.00 Mn |
| Mar 31, 2022 | -348.00 Mn |
| Dec 31, 2021 | 131.00 Mn |
| Sep 30, 2021 | 162.00 Mn |